220 publications
Tolvaptan (Jinarc) by cyst development and renal insufficiency of autosomal dominant polycystic kidney disease (ADPKD)
Based on the criteria for mutual replaceability, tolvaptan is not eligible for placing on List 1A of the GVS. Nor is tolvaptan ...
Cost-effectiveness in practice
Cost-effectiveness is one criterion that helps us to make responsible choices. It gives us insight into how much “value we are ...
Moving towards new health care and new health care professions (the contours)
Assessment of established medical science and medical practice
In this report we describe, ‘anno today’, how we assess the criterion ‘established medical science and medical practice‘ and ...
Taking care of good healtcare
Febuxostat (Adenuric) for the treatment of chronic hyperuricaemia
In conclusion, febuxostat can be said to have an equal value in comparison to allopurinol in the treatment of adult patients with ...
Simeprevir (Olysio) for the indication chronic hepatitis C
The therapeutic value of simeprevir in combination with pegIFN and ribavirin for the treatment of chronic hepatitis C genotype 1 ...
Mannitol (Bronchitol) for the indication 'adult patients with cystic fibrosis
The WAR has approved a pharmacotherapeutic report for the medicine mannitol (Bronchitol) capsules with dry powder for inhalation. ...
Dolutegravir (Tivicay) for the indication infection with HIV-1
The WAR has approved a pharmacotherapeutic report for the medicine dolutegravir (Tivicay). In determining its therapeutic value, ...